Kindly MD, Inc.
Kindly MD, Inc. (KDLYW) Stock Overview
Explore Kindly MD, Inc.’s financial performance, market position, analyst ratings, and future outlook.
KDLYW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Kindly MD, Inc. (KDLYW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.09.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -18.85 and a market capitalization of 96.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Timothy Pickett
23
5097 South 900 East, Salt Lake City, UT
1970